Recursion Pharmaceuticals Inc (RXRX)
6.13
-0.40
(-6.13%)
USD |
NASDAQ |
Mar 26, 15:27
Recursion Pharmaceuticals Profit Margin (Quarterly): -3.97K% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Absci Corp | -4.36K% |
| Corcept Therapeutics Inc | 16.90% |
| Catalyst Pharmaceuticals Inc | 39.44% |
| Enanta Pharmaceuticals Inc | -131.4% |
| Apellis Pharmaceuticals Inc | -17.10% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.06% |
| Return on Assets | -55.70% |
| Return on Invested Capital | -74.84% |
| Gross Profit Margin (Quarterly) | -183.6% |
| Operating Margin (Quarterly) | -4.07K% |
| Return on Net Operating Assets | -137.5% |